Dean L Schorno insider trades

Open-market stock purchases and sales by Dean L Schorno, EVP & Chief Financial Officer at Rigel Pharmaceuticals Inc, from SEC Form 4 filings since Jan 13, 2011.

Recent trades

DateStockTradeValue
Jun 17, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Jun 1, 2026RIGL Rigel Pharmaceuticals IncSold (not open market)$27.7K
Jun 1, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Jun 1, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Feb 17, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Feb 10, 2026RIGL Rigel Pharmaceuticals IncSold (not open market)$123K
Feb 2, 2026RIGL Rigel Pharmaceuticals IncSold (not open market)$198K
Dec 22, 2025RIGL Rigel Pharmaceuticals IncBought (not open market)—
Dec 22, 2025RIGL Rigel Pharmaceuticals IncBought (not open market)—
Dec 22, 2025RIGL Rigel Pharmaceuticals IncBought (not open market)—

Companies traded

  • RIGL Rigel Pharmaceuticals Inc: 2 buys, 5 sales, last Jun 17, 2026
  • GHDX Genomic Health Inc: 31 sales, last Jun 10, 2014

Get free alerts when Dean L Schorno files a new trade →